Role

2 Day Role of an Effective HR Advisor Training Course (April 17-20, 2023)

Retrieved on: 
Saturday, March 11, 2023

DUBLIN, March 10, 2023 /PRNewswire/ -- The "The Role of an Effective HR Advisor Training Course" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 10, 2023 /PRNewswire/ -- The "The Role of an Effective HR Advisor Training Course" conference has been added to ResearchAndMarkets.com's offering.
  • The seminar will focus on the key skills needed by the HR advisor, as well as the practical duties required by the role.
  • Are you working in HR and looking to develop your skills to take your career to the next level?
  • This programme will build on your skill set and experience, and give you the knowledge to fully understand the role and responsibilities of an HR advisor.

Wonder Dynamics Officially Launches Wonder Studio, a First of Its Kind AI Tool for the Film and TV Industry

Retrieved on: 
Thursday, March 9, 2023

Wonder Dynamics , an AI film company co-founded by Tye Sheridan—actor/producer known for Ready Player One—and VFX supervisor/filmmaker Nikola Todorovic, today announced the official launch of Wonder Studio, an AI tool built for the film and TV industry.

Key Points: 
  • Wonder Dynamics , an AI film company co-founded by Tye Sheridan—actor/producer known for Ready Player One—and VFX supervisor/filmmaker Nikola Todorovic, today announced the official launch of Wonder Studio, an AI tool built for the film and TV industry.
  • Wonder Studio is a web-based AI platform that enables artists to create films with CGI characters with just a few simple clicks of a button.
  • Instead, the AI analyzes the footage from a single camera and captures many elements, including the actors’ performances, lighting, compositing, camera motion, etc.
  • Wonder Dynamics Co-Founders Tye Sheridan and Nikola Todorovic will be discussing Wonder Studio further in the featured SXSW panel, Understanding the Role of AI in Reshaping the Film & Television Industry , on March 14, 2023.

iHeartPodcast Network Announces First-Ever Influencer Summit Bringing Today’s Leading Creators and Brands Together to Discuss the Future of Podcast Advertising

Retrieved on: 
Thursday, March 9, 2023

The iHeartPodcast Network announced today an industry-first Influencer Summit where some of the most successful podcast creators will open the mic and teach marketers the art of podcast advertising on Wednesday, April 26, 2023, at the iHeartMedia executive offices in New York City.

Key Points: 
  • The iHeartPodcast Network announced today an industry-first Influencer Summit where some of the most successful podcast creators will open the mic and teach marketers the art of podcast advertising on Wednesday, April 26, 2023, at the iHeartMedia executive offices in New York City.
  • According to eMarketer, in the past two years podcasts and influencers have been the fastest growing advertising channel for marketers.
  • The event will feature workshops and provocative, forward-thinking discussions about the future of podcast advertising with iHeart’s most powerful podcast influencers and innovative leaders in marketing to bridge the gap between creators and brands.
  • Collaborating with other iHeartPodcast creators and brands at this event to find the best ways to create compelling podcast marketing for those listeners is exciting,” said Frey.

Charles River Launches Helper Plasmid to Streamline Adeno-Associated Viral Vector Manufacturing

Retrieved on: 
Thursday, March 9, 2023

Alongside a wealth of expert speakers and panel discussions, Ramin Baghirzade, PhD, Senior Director, Global Head Commercial, Gene Therapy CDMO Services will present: The Role of Plasmid DNA in Expediting Gene Therapy Manufacturing and Beyond.

Key Points: 
  • Alongside a wealth of expert speakers and panel discussions, Ramin Baghirzade, PhD, Senior Director, Global Head Commercial, Gene Therapy CDMO Services will present: The Role of Plasmid DNA in Expediting Gene Therapy Manufacturing and Beyond.
  • The addition of pHelper plasmids follows the launch of the eXpDNA™ plasmid manufacturing platform , established over decades of plasmid DNA CDMO scale-up experience, which significantly reduces plasmid production turnaround time for advanced therapy medical product (ATMP) and vaccine developers.
  • In recent years, Charles River has significantly broadened its cell and gene therapy portfolio with several acquisitions and recent expansions to simplify complex supply chains and meet growing global demand for plasmid DNA, viral vector, and cell therapy services.
  • Combined with the Company’s legacy testing services, Charles River offers an industry-leading “concept-to-cure” solution for advanced therapies.

Axonics to Participate in the SUFU 2023 Winter Meeting

Retrieved on: 
Tuesday, March 7, 2023

In addition, data highlighting the experience of patients with Axonics SNM therapy will include three poster presentations:

Key Points: 
  • In addition, data highlighting the experience of patients with Axonics SNM therapy will include three poster presentations:
    The Role of Age in the Effectiveness of SNM for OAB – presented by Ayman Mahdy, M.D., Ph.D.
  • Effectiveness of the Axonics SNM System in Improving Sleep Quality of Life for Patients Suffering with Nocturia – presented by Michael Kennelly, M.D.
  • Efficacy and Durability of the Predictive Programming Algorithm of the Axonics SNM System – presented by Ryan Krlin, M.D.
  • “The SUFU 2023 Winter Meeting provides an opportunity for physicians to learn more about Axonics SNM therapy and the durable symptom relief patients are experiencing, directly from their peers,” said Karen Noblett, M.D., chief medical officer of Axonics.

Formal Leave and Disability Programs Better Prepared Employers for Shifting Worker Needs

Retrieved on: 
Monday, March 6, 2023

A recent study found that 59% of U.S. employers didn’t feel fully prepared to meet their employees’ changing needs and expectations.

Key Points: 
  • A recent study found that 59% of U.S. employers didn’t feel fully prepared to meet their employees’ changing needs and expectations.
  • However, employers with formal leave and disability management programs felt more prepared to support these shifting employee needs.
  • The employers with formal programs did see a rise in factors that signal a more satisfied workforce.
  • The number of employers with formal leave or disability programs reporting greater retention rose more than 25% since 2018.

JMIR MEDICAL EDUCATION LAUNCHES SPECIAL ISSUE ON THE USE OF CHATGPT IN MEDICAL EDUCATION, AFTER NEW STUDY FINDS CHATGPT PASSES THE UNITED STATES MEDICAL LICENSING EXAMINATION

Retrieved on: 
Monday, March 6, 2023

TORONTO and PHILADELPHIA, March 6, 2023 /PRNewswire/ -- A study published on February 8, 2023, in JMIR Medical Education, a leading open access journal on digital medical education, evaluated the potential of ChatGPT, a natural language processing model, as a medical education tool. The study found that ChatGPT reaches the equivalent of a passing score for a third-year medical student. Conducted by researchers from Yale University School of Medicine's Section for Biomedical Informatics and Data Science and University College Dublin, the study aimed to test the performance of ChatGPT and previous-generation large language models on the medical question-answering problem as part of the United States Medical Licensing Examination (USMLE) Step 1 and Step 2 exams.

Key Points: 
  • In their paper titled " How Does ChatGPT Perform on the United States Medical Licensing Examination?
  • JMIR Medical Education Launches a Theme Issue on ChatGPT, Generative Language Models, and AI in Medical Education
    Given the interest this research has generated among medical educators and researchers, JMIR Medical Education has released a call for papers for its upcoming theme issue and e-collection titled "ChatGPT and Generative Language Models in Medical Education " [2].
  • Gilson A, Safranek CW, Huang T, Socrates V, Chi L, Taylor RA, Chartash D. How Does ChatGPT Perform on the United States Medical Licensing Examination?
  • The Implications of Large Language Models for Medical Education and Knowledge Assessment
    Call for Papers for the ChatGPT Theme Issue for JMIR Medical Education: https://mededu.jmir.org/announcements/365
    Eysenbach G. The Role of ChatGPT, Generative Language Models and Artificial Intelligence in Medical Education: A Conversation with ChatGPT and a Call for Papers

PROSTATE CANCER FOUNDATION-FUNDED GENETIC STUDY OF MEN OF AFRICAN ANCESTRY FINDS NEW RISK FACTORS FOR PROSTATE CANCER

Retrieved on: 
Friday, March 3, 2023

LOS ANGELES, March 3, 2023 /PRNewswire/ -- One in six Black men in the United States will be diagnosed with prostate cancer in his lifetime versus one in eight white men. Black men are more likely to be diagnosed at a younger age, with more aggressive disease, and are more than twice as likely to die of prostate cancer. New findings from Prostate Cancer Foundation (PCF)-funded investigators shed light on the genetic underpinnings of this racial disparity and point the way toward more effective screening strategies.

Key Points: 
  • Studies have identified close to 270 genetic variants linked to prostate cancer risk, but genetic researchers have yet to explain the disproportionate risk among men of African ancestry.
  • Nor have they been able to predict which Black men face a high risk for aggressive prostate cancer.
  • The researchers found nine previously undiscovered genetic variants that increased the risk for prostate cancer in men of African ancestry, seven of which are found either largely or exclusively in Black men.
  • One new variant in the 8q24 region, long known to influence prostate cancer risk, is found only in men of African ancestry.

Pathward Joins More Than 2,400 CEOs in Signing Commitment to Advancing Diversity, Equity and Inclusion in the Workplace

Retrieved on: 
Thursday, March 2, 2023

Pathward®, N.A., an industry leading financial empowerment company, today announced that its CEO, Brett Pharr , has joined with more than 2,400 CEOs in signing the CEO Action for Diversity & Inclusion ™ pledge, signaling the company’s commitment to advancing diversity, equity and inclusion in the workplace.

Key Points: 
  • Pathward®, N.A., an industry leading financial empowerment company, today announced that its CEO, Brett Pharr , has joined with more than 2,400 CEOs in signing the CEO Action for Diversity & Inclusion ™ pledge, signaling the company’s commitment to advancing diversity, equity and inclusion in the workplace.
  • Signing the pledge is in line with Pathward’s purpose to power financial inclusion.
  • Pathward is committed to cultivating a workplace that welcomes and respects diverse perspectives and experiences where employees feel encouraged to discuss diversity and inclusion openly.
  • To learn more about the pledge and actionable insights for driving meaningful progress on diversity and inclusion at your organization, visit CEOAction.com .

KKR Releases “Regime Change: The Role of Private Equity in the ‘Traditional’ Portfolio”

Retrieved on: 
Wednesday, March 1, 2023

In almost all instances, adding Private Equity exposure to a diversified portfolio not only boosts absolute returns but also helps deliver better risk-adjusted returns, especially for investors who are concerned about inflation.

Key Points: 
  • In almost all instances, adding Private Equity exposure to a diversified portfolio not only boosts absolute returns but also helps deliver better risk-adjusted returns, especially for investors who are concerned about inflation.
  • According to McVey and Allouani, the following drivers of Private Equity performance warrant investor attention:
    Sector Allocation: Private Equity sector exposures are often meaningfully different from those of Public Equity indices and can often be a significant source of alpha.
  • Broad sector compositions in different vintages of Private Equity funds also tend to be more dynamic than public markets indices, which can take much longer to adjust.
  • That said, as we look forward, we believe that Private Equity Managers can be even more proactive in systematically exiting portfolio investments in fully priced markets.